Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics (대한후두음성언어의학회지)

The Korean Society of Laryngology, Phoniatrics and Logopedics. (대한후두음성언어의학회)
권호 표지

Dogma of Extraesophaghgeal Reflux

식도 외 역류의 도그마

  • Park, Il-Seok (Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hallym University)
  • 박일석 (한림대학교 의과대학 동탄성심병원 이비인후과학교실)
  • Received : 2016.05.13
  • Accepted : 2016.05.19
  • Published : 2016.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Laryngopharyngeal reflux (LPR) disease is an extraoesophageal variant of gastro-esophageal reflux disease that can affect the larynx and pharynx. LPR is associated with symptoms of laryngeal irritation such as throat clearing, coughing, and hoarseness. The main diagnostic methods currently used are laryngoscopy and pH monitoring. The most common laryngoscopic signs are redness and swelling of the throat. However, these findings are not specific of LPR and may be related to other causes or can even be found in healthy individuals. Furthermore, the role of pH monitoring in the diagnosis of LPR is controversial. A therapeutic trial with proton pump inhibitors (PPIs) has been suggested to be cost-effective and useful for the diagnosis of LPR. However, the recommendations of PPI therapy for patients with a suspicion of LPR are based on the results of uncontrolled studies, and high placebo response rates suggest a much more complex and multifactorial pathophysiology of LPR than simple acid reflux. Laryngoscopy and pH monitoring have failed as reliable tests for the diagnosis of LPR. Empirical therapy with PPIs is widely accepted as a diagnostic test and for the treatment of LPR. However, further research is needed to develop a definitive diagnostic test for LPR.

Keywords

References

  1. Koufman JA. Gastroesophageal reflux and voice disorders. In: Rubin, et al. Diagnosis and treatment of voice disorders. 1st ed. New York, Tokyo: Igaku-Shoin;1995. p.161-75.
  2. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 1991;101(Suppl53):1-73.
  3. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease. A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78.
  4. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534-40. https://doi.org/10.1001/jama.294.12.1534
  5. Choi H. Laryngopharyngeal reflux disease. The 2nd digestive disease research lecture. Korea University Digestive Research Institute; 1999. p.25-32.
  6. Little FB, Koufman JA, Kohut RI. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985;94:516-9. https://doi.org/10.1177/000348948509400521
  7. Axford SE, Sharp N, Ross PE. Cell biology of laryngeal epithelial defenses in health and disease: preliminary studies. Ann Otol Rhinol Laryngol 2001;1099-108.
  8. Bough ID Jr, Sataloff RT, Castell DO. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice 1995;9:205-11. https://doi.org/10.1016/S0892-1997(05)80254-1
  9. Postma GN, Belafsky PC, Aviv JE, Koufman JA. Laryngopharyngeal reflux testing. Ear Nose Throat J 2002;81:14-8. https://doi.org/10.1177/014556130208100105
  10. Park KH, Choi SM, Kwon SU, Yoon SW, Kim SU. Diagnosis of laryngopharyngeal reflux among globus patients. Otolaryngol Head Neck Surg 2006;134:81-5. https://doi.org/10.1016/j.otohns.2005.08.025
  11. Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J 2002;81(Suppl 2):10-3. https://doi.org/10.1177/014556130208100103
  12. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313-7. https://doi.org/10.1097/00005537-200108000-00001
  13. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-7. https://doi.org/10.1016/S0892-1997(02)00097-8
  14. Yoo CS, Kim DS, Lee SK, Lee BD, Chang HS, Kang JW. A study for causative disease of globus pharyngeus patient who have no pathologic conditions in laryngopharynx. Korean J Otolaryngol-Head Neck Surg 1998;41:1573-8.
  15. Johnson PE, Koufman JA, Nowak LJ. Ambulatory 24-hour doubleprobe pH monitoring: The importance of manometry. Laryngoscope 2001;111:1970-5. https://doi.org/10.1097/00005537-200111000-00019
  16. The American gastroenterological association patient care committee. American gastroenterological association medical position statement: Guidelines on the use of esophageal pH recording. Gastroenterology 1996;110:1981-96. https://doi.org/10.1053/gast.1996.1101981
  17. Johnston BT, Troshinsky MB, Castell JA, Castell DO. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol 1996;91:1181-5.
  18. Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: Value of barium studies compared with 24-hr pH monitoring. Am J Roentgenol 1994;162:621-6. https://doi.org/10.2214/ajr.162.3.8109509
  19. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534-40. https://doi.org/10.1001/jama.294.12.1534
  20. Celik M, Ercan I. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg 2006;14:150-5.
  21. Wu JC. Combined Multichannel Intraluminal Impedance and pH Monitoring for Patients With Suspected Laryngopharyngeal Reflux: Is It Ready to Use? J Neurogastroenterol Motil 2010;16:108-9. https://doi.org/10.5056/jnm.2010.16.2.108
  22. Richter JE, Castell DO. Drugs, foods, and other substances in the cause and treatment of reflux esophagitis. Med Clin North Am 1981;65:1223. https://doi.org/10.1016/S0025-7125(16)31470-5
  23. Sandmark S, Carlsson R, Fausa O. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-bline, randomized, scandinavian multicenter study. Scand J Gastroenterol 1988;23:625-32. https://doi.org/10.3109/00365528809093923
  24. Johnson LF. 24-hour pH monitoring in the study of gastroesophageal reflux. J Clin Gastroenterol 1980;2:387. https://doi.org/10.1097/00004836-198012000-00016
  25. HS Choi. Efficacy profile of cisapride in laryngopharyngeal reflux (LPR)-related symptoms. J Korean Soc Logo Phon 1998;9:115-27.
  26. Koufman JA, Aviv JE, Casino RR, Shaw GY. Laryngopharyngeal reflux: Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngology-Head and Neck Surgery 2002;127:32-5. https://doi.org/10.1067/mhn.2002.125760
  27. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA 2005;294:1534-40. https://doi.org/10.1001/jama.294.12.1534
  28. Humayun F, Hoff PT, Robinson EA, Gunaratnam NT. Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease. Otolaryngol Head Neck Surg 2007;137:936-41. https://doi.org/10.1016/j.otohns.2007.08.011
  29. Vaezi MF. Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence. Am J Med 2003;115(Suppl 3A):97-104.
  30. Simons JP, Rosen CA, Casselbrant ML, Chi DH, Schaitkin BM, Rubinstein EN, et al. Comparison of Pediatric Voice Outcome Survey, Reflux Symptom Index, Reflux Finding Score, and esophageal biopsy results. Archives of Otolaryngology--Head & Neck Surgery 2008;134:837-41. https://doi.org/10.1001/archotol.134.8.837
  31. McGuirt WF. Gastroesophageal reflux and the upper airway. Pediatric clinics of North America 2003;50:487-502. https://doi.org/10.1016/S0031-3955(03)00033-6
  32. Bach K, McGuirt WF, Postma GN. Pediatric laryngopharyngeal reflux. Ear, Nose, & Throat Journal 2002;81:27-31.
  33. Zalesska-Krecicka M, Krecicki T, Iwanczak B, Blitek A, Horobiowska M. Laryngeal manifestations of gastroesophageal reflux disease in children. Acta Oto-laryngologica 2002;122:306-10. https://doi.org/10.1080/000164802753648213
  34. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of anti-reflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-5. https://doi.org/10.1177/000348949510400709
  35. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997;116:41-6. https://doi.org/10.1016/S0194-5998(97)70350-4
  36. Rival R, Wong R, Mendelsohn M. Role of gastroesophageal reflux disease in patients with cervical symptoms. Otolaryngol Head Neck Surg 1995;113:364-9. https://doi.org/10.1016/S0194-5998(95)70069-2
  37. Lacombe PS, Vicente JA, Pages JC, Morselli PL. Causes and problems of nonresponse or poor response to drugs. Drugs 1996;51:552-70. https://doi.org/10.2165/00003495-199651040-00004
  38. Melnikow J, KIefe C. Patient compliance and medical research. J Gen Intern Med 1994;9:96-105. https://doi.org/10.1007/BF02600211
  39. Leuflens HE, Urguhart J. Variability in patterns of drug usage. J Pharm Pharmacol 1994;46(Suppl 1):433-7.
  40. Farup PG. Compliance with anti-ulcer medication during short-term healing phase clinical trials. Aliment Pharmacol Ther 1992;6:179-86.